ArticleInvestigative ophthalmology & visual science2026
Impact of Continuous Positive Airway Pressure Treatment on Retinal Vasculature in Obstructive Sleep Apnea: A 7-Year Follow-Up.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In previous studies, obstructive sleep apnea (OSA) severity at diagnosis was independently associated with retinal arteriolar narrowing and reduced retinal pulse amplitude. Participants with severe untreated OSA showed progressive retinal arterial narrowing 2 years post diagnosis, while the use of continuous positive airway pressure (CPAP) ventilation appeared to attenuate these changes. This 7-year prospective study examines whether these protective effects of CPAP persist. Methods: We invited 79 participants from the 2-year follow-up cohort for a 7-year review. Of these, 39 completed assessments: medical history, optical coherence tomography, and retinal vessel imaging. The retinal nerve fiber layer (RNFL) thickness, central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and arteriovenous ratio were analyzed. Results: CRAE and CRVE appeared greater in patients with severe OSA + CPAP than untreated OSA. Over 7 years, CRVE observably declined more slowly in severe those with OSA + CPAP than those with untreated severe OSA. Severe OSA + CPAP had a notable smaller decline in CRAE comparison with the control and untreated groups. The RNFL thickness was nonsignificantly reduced in severe OSA + no CPAP compared with those with CPAP in the superotemporal sector. Global RNFL rates of thinning were equivalent across groups. There was a trend for those not on CPAP to have higher rates of hypertension and stroke. Conclusions: In this cohort, the cohort size was too small for robust statistics. It can still be broadly appreciated that CPAP provides long-term protective benefit against retinal arterial narrowing. The protective effect of CPAP on retinal vascular changes seen at the 2-year mark continued to trend in the mean CRAE values and was also potentially demonstrated in preservation of RNFL thickness in this 7-year study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.